Article
AJMC® in the Press, March 1, 2019
Author(s):
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article from The American Journal of Managed Care®’s sister site The Center for Biosimilars® was highlighted by OBR Oncology’s daily newsfeed. The article, “Ahead of FDA Decision on its Pegfilgrastim Biosimilar, Sandoz Sues Amgen,” reported on Sandoz filing suit against Amgen, asking the United States District Court for the Northern District of California for a declaratory judgment of patent noninfringement and invalidity.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Videos
Related Content
